Table 1 Demographics and clinicopathologic characteristics of non-secondary primary malignancies and the secondary primary malignancies group in the GC patients.

From: Analyzing risk factors for second malignancies in early gastric carcinoma from the SEER database

Variables

Total (n = 3289)

NOSM (n = 3134)

OSM (n = 155)

P

Age.cat, n (%)

   

0.159

18–65

1017 (30.9)

969 (30.9)

48 (31)

 

66–75

944 (28.7)

890 (28.4)

54 (34.8)

 

76–100

1328 (40.4)

1275 (40.7)

53 (34.2)

 

Sex, n (%)

   

0.173

Female

1220 (37.1)

1171 (37.4)

49 (31.6)

 

Male

2069 (62.9)

1963 (62.6)

106 (68.4)

 

Race, n (%)

   

0.973

White

2357 (71.7)

2246 (71.7)

111 (71.6)

 

Black

397 (12.1)

379 (12.1)

18 (11.6)

 

Others

535 (16.3)

509 (16.2)

26 (16.8)

 

Marital, n (%)

   

0.086

Married

1795 (54.6)

1699 (54.2)

96 (61.9)

 

Divorced/Separated

293 (8.9)

285 (9.1)

8 (5.2)

 

Single/UnMarried

385 (11.7)

364 (11.6)

21 (13.5)

 

Widowed/Others

816 (24.8)

786 (25.1)

30 (19.4)

 

Diagnosis, n (%)

   

0.005

2010–2012

1644 (50)

1549 (49.4)

95 (61.3)

 

2013–2015

1645 (50)

1585 (50.6)

60 (38.7)

 

AJCCa, n (%)

   

0.804

IA

2896 (88.1)

2761 (88.1)

135 (87.1)

 

IB

393 (11.9)

373 (11.9)

20 (12.9)

 

AJCC.T, n (%)

   

0.012

T1a

1488 (45.2)

1414 (45.1)

74 (47.7)

 

T1b

889 (27)

836 (26.7)

53 (34.2)

 

T1NOS

912 (27.7)

884 (28.2)

28 (18.1)

 

Region.nodes, n (%)

   

0.055

0

1866 (56.7)

1788 (57.1)

78 (50.3)

 

0–10

522 (15.9)

487 (15.5)

35 (22.6)

 

11–84

901 (27.4)

859 (27.4)

42 (27.1)

 

Radiotherapy, n (%)

   

1

NO

2836 (86.2)

2702 (86.2)

134 (86.5)

 

YES

453 (13.8)

432 (13.8)

21 (13.5)

 

Chemotherapy, n (%)

   

0.668

NO

2664 (81)

2541 (81.1)

123 (79.4)

 

YES

625 (19)

593 (18.9)

32 (20.6)

 

Surgery.method, n (%)

   

0.003

None

1282 (39)

1243 (39.7)

39 (25.2)

 

biopsy/local excision

346 (10.5)

322 (10.3)

24 (15.5)

 

Others

590 (17.9)

557 (17.8)

33 (21.3)

 

Subtotal& Total resection

1071 (32.6)

1012 (32.3)

59 (38.1)

 

Grade, n (%)

   

0.396

I

361 (11)

345 (11)

16 (10.3)

 

II

970 (29.5)

916 (29.2)

54 (34.8)

 

III

1263 (38.4)

1212 (38.7)

51 (32.9)

 

IV/Unknown

695 (21.1)

661 (21.1)

34 (21.9)

 

Hist.type, n (%)

   

0.037

AC

2486 (75.6)

2373 (75.7)

113 (72.9)

 

Others

95 (2.9)

85 (2.7)

10 (6.5)

 

SRCC

708 (21.5)

676 (21.6)

32 (20.6)

 

Primary.site, n (%)

   

0.213

Cardiac/Gastric fundus

1445 (43.9)

1370 (43.7)

75 (48.4)

 

Gastric antrum/Pylorus

774 (23.5)

744 (23.7)

30 (19.4)

 

Gastric body

300 (9.1)

287 (9.2)

13 (8.4)

 

Greater curvature

113 (3.4)

103 (3.3)

10 (6.5)

 

Lesser curvature

237 (7.2)

226 (7.2)

11 (7.1)

 

Overlapping/NOS

420 (12.8)

404 (12.9)

16 (10.3)

 
  1. Data are expressed as n (%) unless otherwise specified.
  2. aAJCC, American Joint Committee on Cancer.